531P Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations (mts): Preliminary results of the investigator initiated phase II BEAVER trial

Authors: A. Rose, O. Ayodele, S. Genta, T. Pimentel Muniz, D.C. Kelly, K. Hodgson, I. King, T. Stockley, T. Pugh, Z. Saeed Kamil, M.O. Butler, F.A. Shepherd, P. Bedard, N. Leighl, A.R. Abdul Razak, A.R. Hansen, S. Saibil, D.W. Cescon, L.L. Siu, A. Spreafico

Published: 2021-09-21

DOI: 10.1016/j.annonc.2021.08.1053

Source: Full article

---

Abstract

No abstract found.